Search

• A machine learning framework is proposed to detect rare conditions in images. • This framework is evaluated in a dataset of 164,660 retinal screening examinations. • 37 conditions can be detected accurately in fundus photographs. • The location of pathological signs can be highlighted in images. • This is expected to increase the confidence in AI-based eye screening. In the last decades, large datasets of fundus photographs have been collected in diabetic retinopathy (DR) screening networks. Through deep learning, these datasets were used to train automatic detectors for DR and a few other frequent pathologies, with the goal to automate screening. One challenge limits the adoption of such systems so far: automatic detectors ignore rare conditions that ophthalmologists currently detect, such as papilledema or anterior ischemic optic neuropathy. The reason is that standard deep learning requires too many examples of these conditions. However, this limitation can be addressed with few-shot learning, a machine learning paradigm where a classifier has to generalize to a new category not seen in training, given only a few examples of this category. This paper presents a new few-shot learning framework that extends convolutional neural networks (CNNs), trained for frequent conditions, with an unsupervised probabilistic model for rare condition detection. It is based on the observation that CNNs often perceive photographs containing the same anomalies as similar, even though these CNNs were trained to detect unrelated conditions. This observation was based on the t-SNE visualization tool, which we decided to incorporate in our probabilistic model. Experiments on a dataset of 164,660 screening examinations from the OPHDIAT screening network show that 37 conditions, out of 41, can be detected with an area under the ROC curve (AUC) greater than 0.8 (average AUC: 0.938). In particular, this framework significantly outperforms other frameworks for detecting rare conditions, including multitask learning, transfer learning and Siamese networks, another few-shot learning solution. We expect these richer predictions to trigger the adoption of automated eye pathology screening, which will revolutionize clinical practice in ophthalmology. [ABSTRACT FROM AUTHOR]

• An explanatory artificial intelligence framework is presented for image classification. • It classifies each pixel and the image as a whole with image-level supervision only. • A novel self-supervised approach is presented for foreground/background separation. • The image classification process can be explained visually and possibly in text form. • For diabetic retinopathy grading, explainability does not reduce classification performance. [Display omitted] In recent years, Artificial Intelligence (AI) has proven its relevance for medical decision support. However, the "black-box" nature of successful AI algorithms still holds back their wide-spread deployment. In this paper, we describe an eXplanatory Artificial Intelligence (XAI) that reaches the same level of performance as black-box AI, for the task of classifying Diabetic Retinopathy (DR) severity using Color Fundus Photography (CFP). This algorithm, called ExplAIn, learns to segment and categorize lesions in images; the final image-level classification directly derives from these multivariate lesion segmentations. The novelty of this explanatory framework is that it is trained from end to end, with image supervision only, just like black-box AI algorithms: the concepts of lesions and lesion categories emerge by themselves. For improved lesion localization, foreground/background separation is trained through self-supervision, in such a way that occluding foreground pixels transforms the input image into a healthy-looking image. The advantage of such an architecture is that automatic diagnoses can be explained simply by an image and/or a few sentences. ExplAIn is evaluated at the image level and at the pixel level on various CFP image datasets. We expect this new framework, which jointly offers high classification performance and explainability, to facilitate AI deployment. [ABSTRACT FROM AUTHOR]

• multi-view information fusion can improve computer-aided diagnosis of breast cancer • a new deep Siamese pipeline is proposed for mass detection from dual-view mammograms • multi-tasking abilities of deep models are used to learn matching and classification • dual-view matching improves both patch classification and examination-level detection • our automatic mass detector could act as second opinion for mammogram interpretation [Display omitted] Breast cancer screening benefits from the visual analysis of multiple views of routine mammograms. As for clinical practice, computer-aided diagnosis (CAD) systems could be enhanced by integrating multi-view information. In this work, we propose a new multi-tasking framework that combines craniocaudal (CC) and mediolateral-oblique (MLO) mammograms for automatic breast mass detection. Rather than addressing mass recognition only, we exploit multi-tasking properties of deep networks to jointly learn mass matching and classification, towards better detection performance. Specifically, we propose a unified Siamese network that combines patch-level mass/non-mass classification and dual-view mass matching to take full advantage of multi-view information. This model is exploited in a full image detection pipeline based on You-Only-Look-Once (YOLO) region proposals. We carry out exhaustive experiments to highlight the contribution of dual-view matching for both patch-level classification and examination-level detection scenarios. Results demonstrate that mass matching highly improves the full-pipeline detection performance by outperforming conventional single-task schemes with 94.78% as Area Under the Curve (AUC) score and a classification accuracy of 0.8791. Interestingly, mass classification also improves the performance of mass matching, which proves the complementarity of both tasks. Our method further guides clinicians by providing accurate dual-view mass correspondences, which suggests that it could act as a relevant second opinion for mammogram interpretation and breast cancer diagnosis. [ABSTRACT FROM AUTHOR]